These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease. Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA; Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714 [TBL] [Abstract][Full Text] [Related]
26. [Obesity and cardiovascular morbidity]. Berg A; Bönner G Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824 [No Abstract] [Full Text] [Related]
28. Achieving cholesterol goals. Current and future drug therapies. Jones PH Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635 [TBL] [Abstract][Full Text] [Related]
29. Should women with normal cholesterol be taking a statin? A major study suggests that statins also quell inflammation. Now what? Harv Womens Health Watch; 2009 Feb; 16(6):1-3. PubMed ID: 19297742 [No Abstract] [Full Text] [Related]
30. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. O'Keefe JH; Cordain L; Harris WH; Moe RM; Vogel R J Am Coll Cardiol; 2004 Jun; 43(11):2142-6. PubMed ID: 15172426 [TBL] [Abstract][Full Text] [Related]
31. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
32. The case for medical treatment in chronic stable coronary artery disease. Nash DT Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414 [No Abstract] [Full Text] [Related]
33. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients]. Nilsson PM; Attvall S; Båvenholm P Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534 [No Abstract] [Full Text] [Related]
34. Low high-density lipoprotein cholesterol and chronic disease risk marker or causal? Robinson JG J Am Coll Cardiol; 2010 Jun; 55(25):2855-7. PubMed ID: 20579543 [No Abstract] [Full Text] [Related]
35. [HDL-cholesterol-- active or passive participant in the pathogenesis of atherosclerosis]. Artenie R; Ungureanu D; Artenie A; Botnariu G; Anisie E Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):282-7. PubMed ID: 14755929 [TBL] [Abstract][Full Text] [Related]
36. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too. Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517 [No Abstract] [Full Text] [Related]
38. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?]. Vaverková H Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178 [TBL] [Abstract][Full Text] [Related]
39. [Treatment with statins: lowering of cholesterol or more?]. Rutishauser J Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605 [No Abstract] [Full Text] [Related]
40. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c. Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL; Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]